MarketWatch: Construction for Hakkasan Las Vegas Underway at MGM Grand Hotel & Casino

From MarketWatch:

Construction is underway for Hakkasan Las Vegas, an upscale dining experience with a lavish lounge and nightclub created by Hakkasan Ltd. and its partners Angel Management Group (AMG). Unveiling this December at MGM Grand Hotel & Casino, the notable development has taken over the former Studio 54 space and the main exterior facade at one of the busiest intersections on The Strip: Las Vegas Boulevard South and Tropicana Avenue.

Spanning approximately 75,000-square-feet over five levels, the space will offer a number of experiences including Hakkasan's signature restaurant and lounge as well as a new nightclub component, signifying an evolution of the prestigious brand that is unique to its Las Vegas location. The two venues will embody the design philosophy of Hakkasan, built on the design foundations of the luxurious interior at its flagship London location. Hakkasan Las Vegas will capture the distinctive modern Chinoiserie with rich interiors, epitomizing a cool charm that translates into a luxurious and contemporary environment.

Niall Howard, CEO of Hakkasan, said, "With Las Vegas as our fourth opening in the U.S., we are pleased to be part of such an established city, known widely for its impeccable dining and entertainment offerings." He added, "We are thrilled to partner with Angel Management Group who we see as the best nightclub operators in the United States."

Neil Moffitt, CEO of Angel Management Group said, "We are delighted to work with Hakkasan Ltd. to introduce one of the world's finest and most well-respected dining brands as well as a new nightlife concept to MGM Grand. This will be the first of its kind in the market, delivering an unparalleled environment for guests to indulge in and experience."

. . .

For full article visit, MarketWatch.


Suggested Articles

A breakdown of the latest $1 trillion from the Senate.

The number of businesses switching from temporary to permanent closures surpasses 50%.

The coronavirus continues to threaten our industry but there are promising medical developments and still many questions on the next round of relief.